Pathways to ischemic neuronal cell death: are sex differences relevant?

<p>Abstract</p> <p>We have known for some time that the epidemiology of human stroke is sexually dimorphic until late in life, well beyond the years of reproductive senescence and menopause. Now, a new concept is emerging: the <it>mechanisms </it>and <it>outcome &...

Full description

Bibliographic Details
Main Authors: McCullough Louise D, Lang Jesse T
Format: Article
Language:English
Published: BMC 2008-06-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/6/1/33
id doaj-0cf838b27b664b8f9d8bbb1ad94f6f6e
record_format Article
spelling doaj-0cf838b27b664b8f9d8bbb1ad94f6f6e2020-11-24T21:19:08ZengBMCJournal of Translational Medicine1479-58762008-06-01613310.1186/1479-5876-6-33Pathways to ischemic neuronal cell death: are sex differences relevant?McCullough Louise DLang Jesse T<p>Abstract</p> <p>We have known for some time that the epidemiology of human stroke is sexually dimorphic until late in life, well beyond the years of reproductive senescence and menopause. Now, a new concept is emerging: the <it>mechanisms </it>and <it>outcome </it>of cerebral ischemic injury are influenced strongly by biological sex as well as the availability of sex steroids to the brain. The principal mammalian estrogen (17 β estradiol or E2) is neuroprotective in many types of brain injury and has been the major focus of investigation over the past several decades. However, it is becoming increasingly clear that although hormones are a major contributor to sex-specific outcomes, they do not fully account for sex-specific responses to cerebral ischemia. The purpose of this review is to highlight recent studies in cell culture and animal models that suggest that genetic sex determines experimental stroke outcome and that divergent cell death pathways are activated after an ischemic insult. These sex differences need to be identified if we are to develop efficacious neuroprotective agents for use in stroke patients.</p> http://www.translational-medicine.com/content/6/1/33
collection DOAJ
language English
format Article
sources DOAJ
author McCullough Louise D
Lang Jesse T
spellingShingle McCullough Louise D
Lang Jesse T
Pathways to ischemic neuronal cell death: are sex differences relevant?
Journal of Translational Medicine
author_facet McCullough Louise D
Lang Jesse T
author_sort McCullough Louise D
title Pathways to ischemic neuronal cell death: are sex differences relevant?
title_short Pathways to ischemic neuronal cell death: are sex differences relevant?
title_full Pathways to ischemic neuronal cell death: are sex differences relevant?
title_fullStr Pathways to ischemic neuronal cell death: are sex differences relevant?
title_full_unstemmed Pathways to ischemic neuronal cell death: are sex differences relevant?
title_sort pathways to ischemic neuronal cell death: are sex differences relevant?
publisher BMC
series Journal of Translational Medicine
issn 1479-5876
publishDate 2008-06-01
description <p>Abstract</p> <p>We have known for some time that the epidemiology of human stroke is sexually dimorphic until late in life, well beyond the years of reproductive senescence and menopause. Now, a new concept is emerging: the <it>mechanisms </it>and <it>outcome </it>of cerebral ischemic injury are influenced strongly by biological sex as well as the availability of sex steroids to the brain. The principal mammalian estrogen (17 β estradiol or E2) is neuroprotective in many types of brain injury and has been the major focus of investigation over the past several decades. However, it is becoming increasingly clear that although hormones are a major contributor to sex-specific outcomes, they do not fully account for sex-specific responses to cerebral ischemia. The purpose of this review is to highlight recent studies in cell culture and animal models that suggest that genetic sex determines experimental stroke outcome and that divergent cell death pathways are activated after an ischemic insult. These sex differences need to be identified if we are to develop efficacious neuroprotective agents for use in stroke patients.</p>
url http://www.translational-medicine.com/content/6/1/33
work_keys_str_mv AT mcculloughlouised pathwaystoischemicneuronalcelldeatharesexdifferencesrelevant
AT langjesset pathwaystoischemicneuronalcelldeatharesexdifferencesrelevant
_version_ 1726006876157509632